is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Real time results when and where you need them.
Fast Diagnosis and Treatment
In 13 minutes or less, the speed of the rapid, molecular ID NOW™ platform enhances clinical confidence and allows immediate decision-making.
ID NOW™ is a nucleic acid amplification test (NAAT) that uses isothermal nicking enzyme amplification reaction (NEAR) technology to provide real-time molecular results in a fraction of the time it takes traditional lab tests.
Simple and Smart Technology
With a small footprint, the ID NOW platform can be placed anywhere, allowing near-patient testing or triaging for the earliest possible results. ID NOW™ simplifies the test process with intuitive operation, no manual pipetting and no diagnostic expertise required to perform testing. Tests are stored at room temperature and can be run on demand, right out of the box.
A full respiratory portfolio of COVID-19, influenza A & B, RSV, and strep A gives you the flexibility to test based on patient presentation, circulating prevalence and seasonality. The ID NOW platform also gives you the option to test for COVID-19 only or test for COVID-19 and influenza A & B using a single patient swab sample.